Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
En-Qiang Chen, Ying Shi, Dong-Bo Wu & Hong Tang. (2014) Liquid oral suspension adefovir dipivoxil (GS-02-526): an update on treatments for hepatitis B infection. Expert Review of Anti-infective Therapy 12:8, pages 919-928.
Read now
Read now
Evangelista Sagnelli, Mariantonietta Pisaturo, Salvatore Martini, Caterina Sagnelli, Pietro Filippini & Nicola Coppola. (2014) Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection. Expert Opinion on Pharmacotherapy 15:10, pages 1337-1349.
Read now
Read now
Articles from other publishers (18)
Yumi Kawakatsu-Hatada, Soichiro Murata, Akihiro Mori, Kodai Kimura & Hideki Taniguchi. (2021) Serous Membrane Detachment with Ultrasonic Homogenizer Improves Engraftment of Fetal Liver to Liver Surface in a Rat Model of Cirrhosis. International Journal of Molecular Sciences 22:21, pages 11589.
Crossref
Crossref
Yasunori Nio, Yuichi Akahori, Hitomi Okamura, Koichi Watashi, Takaji Wakita & Makoto Hijikata. (2018) Inhibitory effect of fasiglifam on hepatitis B virus infections through suppression of the sodium taurocholate cotransporting polypeptide. Biochemical and Biophysical Research Communications 501:3, pages 820-825.
Crossref
Crossref
M. Viganò, F. Invernizzi, G. Grossi & P. Lampertico. (2016) Review article: the potential of interferon and nucleos(t)ide analogue combination therapy in chronic hepatitis B infection. Alimentary Pharmacology & Therapeutics 44:7, pages 653-661.
Crossref
Crossref
Renesh H. Bedre, Utkarsh Raj, Sri Prakash Misra & Pritish Kumar Varadwaj. (2016) Antiviral therapy with nucleotide/nucleoside analogues in chronic hepatitis B: A meta-analysis of prospective randomized trials. Indian Journal of Gastroenterology 35:2, pages 75-82.
Crossref
Crossref
Krzysztof Domagalski, Małgorzata Pawłowska, Agnieszka Zaleśna, Małgorzata Pilarczyk, Paweł Rajewski, Waldemar Halota & Andrzej Tretyn. (2016)
Impact of IL28B and
OAS
gene family polymorphisms on interferon treatment response in Caucasian children chronically infected with hepatitis B virus
. World Journal of Gastroenterology 22:41, pages 9186.
Crossref
Crossref
Mauro Viganò, Massimo Puoti & Pietro Lampertico. 2016. Hepatitis B Virus in Human Diseases. Hepatitis B Virus in Human Diseases
339
359
.
En-Qiang Chen, Jie Dai, Lang Bai & Hong Tang. (2015) The efficacy of zinc finger antiviral protein against hepatitis B virus transcription and replication in tansgenic mouse model. Virology Journal 12:1.
Crossref
Crossref
Pietro Lampertico, Federica Invernizzi, Mauro Vigan?Alessandro Loglio, Giampaolo Mangia, Floriana Facchetti, Massimo Primignani, Manol Jovani, Massimo Iavarone, Mirella Fraquelli, Giovanni Casazza, Roberto de Franchis & Massimo Colombo. (2015) The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices: A 12-year prospective cohort study. Journal of Hepatology 63:5, pages 1118-1125.
Crossref
Crossref
Mauro Viganò, Sherrie Bhoori, Pietro Lampertico, Maria Francesca Donato, Massimo Iavarone, Glenda Grossi, Antonio Facciorusso, Lucio Caccamo, Giorgio Rossi, Massimo Colombo & Vincenzo Mazzaferro. (2015) Extended survival of patients with persistently suppressed hepatitis B transplanted for hepatocellular carcinoma. Liver International 35:9, pages 2187-2193.
Crossref
Crossref
Xue-jun Wang, Wei Hu, Ting-yu Zhang, Ying-ying Mao, Nan-nan Liu & Sheng-qi Wang. (2015) Irbesartan, an FDA approved drug for hypertension and diabetic nephropathy, is a potent inhibitor for hepatitis B virus entry by disturbing Na+-dependent taurocholate cotransporting polypeptide activity. Antiviral Research 120, pages 140-146.
Crossref
Crossref
Mauro Viganò, Federica Invernizzi & Pietro Lampertico. (2015) Optimal therapy of chronic hepatitis B: how do I treat my HBeAg-negative patients?. Liver International 35, pages 107-113.
Crossref
Crossref
K. Domagalski, M. Pawłowska, A. Zaleśna, M. Tyczyno, M. Skorupa-Kłaput, A. Tretyn & W. Halota. (2014) The relationship between IL-28B polymorphisms and the response to peginterferon alfa-2a monotherapy in anti-HBe-positive patients with chronic HBV infection. European Journal of Clinical Microbiology & Infectious Diseases 33:11, pages 2025-2033.
Crossref
Crossref
Zuowei Zhang, Jun Zhang, Xiaoyu Pei, Qi Zhang, Bin Lu, Xiaojiao Zhang & Jie Liu. (2014) An aptamer targets HBV core protein and suppresses HBV replication in HepG2.2.15 cells. International Journal of Molecular Medicine.
Crossref
Crossref
E. Galmozzi, M. Viganò & P. Lampertico. (2014) Systematic review with meta-analysis: do interferon lambda 3 polymorphisms predict the outcome of interferon-therapy in hepatitis B infection?. Alimentary Pharmacology & Therapeutics 39:6, pages 569-578.
Crossref
Crossref
Mauro Viganò, Giampaolo Mangia & Pietro Lampertico. (2014) HBeAg-negative chronic hepatitis B: why do I treat my patients with nucleos(t)ide analogues?. Liver International 34, pages 120-126.
Crossref
Crossref
En Qiang Chen, Lang Bai, Lan Lan Chen, Tao You Zhou, Ling Yao Du & Hong Tang. (2013) Prolonged Combination Therapy is More Effective than Monotherapy in Management of Chronic Hepatitis B Patients With Sustained Virological Response: An Experience From a ‘Real-World’ Clinical Setting. Iranian Red Crescent Medical Journal 15:12.
Crossref
Crossref
Mauro Viganò, Giampaolo Mangia & Pietro Lampertico. (2013) Results of Treatment of Chronic Hepatitis B with Pegylated Interferon. Clinics in Liver Disease 17:3, pages 425-443.
Crossref
Crossref
Wei Wang, Yang Liu, Xiangyang Zu, Rui Jin & Gengfu Xiao. (2011) Blocking peptides against HBV: PreS1 protein selected from a phage display library. Biochemical and Biophysical Research Communications 412:4, pages 633-637.
Crossref
Crossref